“…Because of their ultra-short half time they are more difficult to detect in whole blood, homogenates, or breath [19,20]. Volatile aldehydes have been studied as specific markers of LPO in asthma/chronic obstructive pulmonary disease [21], ARDS [22], in bone marrow after total body X-ray irradiation [23], in diabetes mellitus [24], and diabetic nephropathy [25], malnutrition [26], atherosclerosis [27], stroke patients [13], and most recently in brain tumors [28]. However, no comparative study has been performed yet for different LPO-marker pattern between various organ failures including these volatile aldehydes.…”